EM2203H "Approaching gliomas through a translational research lens" (IM GR-031822)
Purpose and Overview
The purpose of this talk is to give an overview of gliomas in terms of the presentation, approach to clinical management based on tumor grading and key molecular features, and outcomes. The goal is not to focus solely on the seemingly immovable median survival numbers or the progressive neurological symptoms that ensue with tumor growth. Rather, key points of vulnerability will be outlined in the clinical course of disease and the translational research approaches that are being deployed in making progress toward cure will be discussed.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Identify the critical genetic alterations that determine prognosis in glioma
- Understand the factors that are important in determining treatment timing in low-grade gliomas
- Identify the major translational research questions that, if addressed, could improve survival in glioblastoma and the IDH-mutant gliomas
Elizabeth Maher, M.D., Ph.D.
Professor of Internal Medicine and Neurology
Division of Hematology and Oncology
- 1.00 AMA